Cetuximab improves AZD6244 antitumor activity in sorted by
relevance

Admin01.10.2021

Cetuximab improves AZD6244 antitumor activity in

Admin26.07.2021

Cetuximab improves AZD6244 antitumor activity in

1505
Admin05.08.2021

Cetuximab improves AZD6244 antitumor activity in

7307
Admin01.09.2021

Cetuximab improves AZD6244 antitumor activity in

1502
Admin03.10.2021

Effect of KRAS knockdown on viability of cells harboring a

6406
Admin04.08.2021

Cetuximab improves AZD6244 antitumor activity in

304
Admin04.08.2021

Ge Wangs research works | Third Military Medical

78010
Admin25.07.2021

MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential

Admin13.08.2021

MEK1/2 Inhibitors AS703026 and AZD6244 May Be Potential

Admin24.08.2021

The combination of cetuximab with celecoxib improves the

Admin02.09.2021

Effect of KRAS knockdown on viability of cells harboring a

9707
Admin14.07.2021

(PDF) The addition of celecoxib improves the antitumor

9405
Admin24.07.2021

Combining mAb and CIK cells improves the in vivo antitumor

38010
Admin15.07.2021

Targeting GPCR-Mediated p70S6K Activity May Improve Head

Admin26.09.2021

Effect of KRAS knockdown on viability of cells harboring a

Admin24.07.2021

(PDF) Targeting GPCR-Mediated p70S6K Activity May Improve

1702
Admin10.09.2021

mAb-A22p antibodies exhibit improved antitumor efficacy

209
Admin21.08.2021

Targeting GPCR-Mediated p70S6K Activity May Improve Head

31010
Admin19.09.2021

Ge Wangs research works | Third Military Medical

7700
Admin28.09.2021

Representative tumor growth curves from the panel of HNSCC

12010
Admin29.09.2021

Combining mAb and CIK cells improves the in vivo antitumor

6808